Home > Healthcare > Pharmaceuticals > Finished Drug Form > Platelet and Plasma Market
Platelet and Plasma Market size was more than USD 6.1 billion in 2019 and will witness 2.2% CAGR during 2020 to 2026. Platelet and plasma are critical parts of the treatment for several serious health problems. Platelets are tiny cell components of blood that helps in formation of blood clot to stop bleeding while plasma is a liquid component of blood that takes hormones, nutrients, and proteins to the different parts of body.
Increasing demand of platelet and plasma for the treatment of life-threatening diseases and deficiencies such as hemophilia, thrombocytopenia, coagulation factor deficiencies, liver disease along with other blood disorders will upsurge the industry growth. Favourable reimbursement policies in developed countries will further boost market demand over the projected timeline.
Report Attribute | Details |
---|---|
Base Year: | 2019 |
Platelet & Plasma Market Size in 2019: | USD 6,132.4 Million |
Forecast Period: | 2020 to 2026 |
Forecast Period 2020 to 2026 CAGR: | 2.2% |
2026 Value Projection: | USD 7,176.0 Million |
Historical Data for: | 2015 to 2019 |
No. of Pages: | 110 |
Tables, Charts & Figures: | 91 |
Segments covered: | Component, Application, Distribution Channel and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|